Maintenance of a Normal Meal-induced Decrease in Plasma Ghrelin Levels in Children with Prader-Willi Syndrome

 

 Buy Article Permissions and Reprints

Abstract

Ghrelin is a 28-amino acid peptide recently identified in the stomach as the endogenous ligand for the growth hormone secretagogue receptor (GHS-R1a). Ghrelin is a potent stimulator of GH secretion. It was recently shown that circulating ghrelin levels in humans rise shortly before and fall shortly after every meal, and that ghrelin administration increases voluntary food intake. The hypothesis that ghrelin hypersecretion might contribute to genetic obesity has never been investigated. In this context, Prader-Willi syndrome is the most common form of human syndromic obesity. As ghrelin affects appetite as well as GH secretion and both are abnormal in PWS, it has been surmised that these alterations might be due to ghrelin dysregulation. The aim of the study was to investigate whether ghrelin is suppressed by the meals differently in PWS children than in PWS adults. Overnight circulating fasting ghrelin levels and ghrelin levels 120 min after breakfast were assayed in 7 PWS children (10.2 ± 1.7 yr), 7 subjects with morbid obesity (10.3 ± 1.3 yr), and 5 normal controls (8.4 ± 1.4 yr). Because of the data spread, no statistical difference was observed in fasting ghrelin levels between PWS and control children (p = NS); anyway, fasting ghrelin levels were significantly lower in obese children than in the other groups (p < 0.05 vs. control and PWS children). Ghrelin levels were slightly suppressed by the meal in control subjects (mean fasting ghrelin: 160.2 ± 82 pg/ml; after the meal, 141.2 ± 57 pg/ml, p = NS); the meal failed to suppress ghrelin levels in obese children (mean fasting ghrelin: 126.4 ± 8.5 pg/ml; after the meal, 119.1 ± 8.3 pg/ml, p = NS). Interestingly, the meal markedly suppressed ghrelin levels in PWS children (mean fasting ghrelin: 229.5 ± 70.4 pg/ml; after the meal, 155.8 ± 34.2 pg/ml, p < 0.01). In conclusion, since a lack of decrease in circulating ghrelin induced by the meal was previously reported in PWS adults, the finding of a meal-induced decrease in ghrelin levels in our population of young PWS would imply that the regulation of the ghrelin system involved in the orexigenic effects of the peptide is operative during childhood, although it progressively deteriorates and is absent in adulthood when hyperphagia and obesity progressively worsen.

References

• 1 Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach.  Nature. 1999;  402 656-660
  CrossrefPubMedGoogle Scholar
• 2 Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal M S, Suganuma T, Matsukura S, Kangawa K, Nakazato M. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans.  Endocrinology. 2000;  141 4255-4261
  CrossrefPubMedGoogle Scholar
• 3 Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal M S, Hosoda H, Kojima M, Kangawa K, Arima T, Matsuo H, Yada T, Matsukura S. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion.  Diabetes. 2002;  51 124-129
  CrossrefPubMedGoogle Scholar
• 4 Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K. Ghrelin strongly stimulates growth hormone release in humans.  J Clin Endocrinol Metab. 2000;  85 4908-4911
  CrossrefPubMedGoogle Scholar
• 5 Gnanapavan S, Kola B, Bustin S A, Morris D G, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman A B, Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans.  J Clin Endocrinol Metab. 2002;  87 2988
  CrossrefPubMedGoogle Scholar
• 6 Tschop M, Wawarta R, Riepl R L, Friedrich S, Bidlingmaier M, Landgraf R, Folwaczny C. Post-prandial decrease of circulating human ghrelin levels.  J Endocrinol Invest. 2001;  24 RC19-21
  PubMedGoogle Scholar
• 7 Wren A M, Seal L J, Cohen M A, Brynes A E, Frost G S, Murphy K G, Dhillo W S, Ghatei M A, Bloom S R. Ghrelin enhances appetite and increases food intake in humans.  J Clin Endocrinol Metab. 2001;  86 5992
  CrossrefPubMedGoogle Scholar
• 8 Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding.  Nature. 2001;  409 194-198
  CrossrefPubMedGoogle Scholar
• 9 Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M, van der Lely A J, Deghenghi R, Ghigo E. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans.  J Clin Endocrinol Metab. 2001;  86 5083-5086
  CrossrefPubMedGoogle Scholar
• 10 Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal M S, Tanaka M, Nozoe S, Hosoda H, Kangawa K, Matsukura S. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion.  J Clin Endocrinol Metab. 2002;  87 240-244
  CrossrefPubMedGoogle Scholar
• 11 Burman P, Ritzen E M, Lindgren A C. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH.  Endocr Rev. 2001;  22 787-799
  CrossrefPubMedGoogle Scholar
• 12 Holm V A, Cassidy S B, Butler M G, Hanchett J M, Greenswag L R, Whitman B Y, Greenberg F. Prader-Willi syndrome: consensus diagnostic criteria.  Pediatrics. 1993;  91 398-402
  PubMedGoogle Scholar
• 13 Wharton R H, Loechner Wharton R H, Loechner K J. Genetic and clinical advances in Prader-Willi syndrome.  Curr Opin Pediatr. 1996;  8 618-624
  PubMedGoogle Scholar
• 14 Cummings D E, Clement K, Purnell J Q, Vaisse C, Foster K E, Frayo R S, Schwartz M W, Basdevant A, Weigle D S. Elevated plasma ghrelin levels in Prader Willi syndrome.  Nat Med. 2002;  8 643-644
  CrossrefPubMedGoogle Scholar
• 15 DelParigi A, Tschop M, Heiman M L, Salbe A D, Vozarova B, Sell S M, Bunt J C, Tataranni P A. High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome.  J Clin Endocrinol Metab. 2002;  87 5461-5464
  CrossrefPubMedGoogle Scholar
• 16 Haqq A M, Farooqi I S, O'Rahilly S, Stadler D D, Rosenfeld R G, Pratt K L, LaFranchi S H, Purnell J Q. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome.  J Clin Endocrinol Metab. 2003;  88 174-178
  CrossrefPubMedGoogle Scholar
• 17 Ward O C. Prader-Willi syndrome.  Lancet. 2000;  356 1856
  PubMedGoogle Scholar
• 18 English P J, Ghatei M A, Malik I A, Bloom S R, Wilding J P. Food fails to suppress ghrelin levels in obese humans.  J Clin Endocrinol Metab. 2002;  87 2984
  CrossrefPubMedGoogle Scholar
• 19 Cummings D E, Schwartz M W. Genetics and pathophysiology of human obesity.  Annu Rev Med. 2003;  54 453-471
  CrossrefPubMedGoogle Scholar
• 20 Bellone S, Rapa A, Vivenza D, Petri A, Me E, Bellone J, Radetti G, Gottero C, Broglio F, Ghigo E, Bona G. Children show refractoriness to the inhibitory effect of feeding on ghrelin secretion. 85th Annual Meeting of the Endocrine Society, June, 19th-23rd 2003, Philadelphia, PA, USA, Abstractbook P1 - 668. 
  Google Scholar
• 21 Rittmaster R S, Loriaux D L, Merriam G R. Effect of continuous somatostatin and growth hormone-releasing hormone (GHRH) infusions on the subsequent growth hormone (GH) response to GHRH. Evidence for somatotroph desensitization independent of GH pool depletion.  Neuroendocrinology. 1987;  45 118-122
  PubMedGoogle Scholar
• 22 Janssen J A, van der Toorn F M, Hofland L J, van Koetsveld P, Broglio F, Ghigo E, Lamberts S W, Jan van der Lely A. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy.  Eur J Endocrinol. 2001;  145 711-716
  CrossrefPubMedGoogle Scholar
• 23 Muller E E, Locatelli V, Cocchi D. Neuroendocrine control of growth hormone secretion.  Physiol Rev. 1999;  79 511-607
  PubMedGoogle Scholar
• 24 Greenswag L R. Adults with Prader-Willi syndrome: a survey of 232 cases.  Dev Med Child Neurol. 1987;  29 145-152
  PubMedGoogle Scholar
• 25 Ott V, Fasshauer M, Dalski A, Meier B, Perwitz N, Klein H H, Tschop M, Klein J. Direct peripheral effects of ghrelin include suppression of adiponectin expression.  Horm Metab Res. 2002;  34 640-645
  Article in Thieme ConnectPubMedGoogle Scholar
• 26 Schuster D P, Osei K, Zipf W B. Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects.  Metabolism. 1996;  45 1514-1520
  CrossrefPubMedGoogle Scholar
• 27 Zipf W B. Glucose homeostasis in Prader-Willi syndrome and potential implications of growth hormone therapy.  Acta Paediatr Suppl.. 1999;  88 115-117
  CrossrefPubMedGoogle Scholar
• 28 Eiholzer U, Stutz K, Weinmann C, Torresani T, Molinari L, Prader A. Low insulin, IGF-I and IGFBP-3 levels in children with Prader-Labhart-Willi syndrome.  Eur J Pediatr. 1998;  157 890-893
  CrossrefPubMedGoogle Scholar
• 29 Hoybye C, Hilding A, Jacobsson H, Thoren M. Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity.  J Clin Endocrinol Metab. 2002;  87 3590-3597
  CrossrefPubMedGoogle Scholar
• 30 Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna R C, Muggeo M. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.  Diabetes. 1998;  47 1643-1649
  CrossrefPubMedGoogle Scholar
• 31 Cummings D E, Purnell J Q, Frayo R S, Schmidova K, Wisse B E, Weigle D S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.  Diabetes. 2001;  50 1714-1719
  CrossrefPubMedGoogle Scholar
• 32 Volante M, Allia E, Gugliotta P, Funaro A, Broglio F, Deghenghi R, Muccioli G, Ghigo E, Papotti M. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors.  J Clin Endocrinol Metab. 2002;  87 1300-1308
  CrossrefPubMedGoogle Scholar
• 33 McCowen K C, Maykel J A, Bistrian B R, Ling P R. Circulating ghrelin concentrations are lowered by intravenous glucose or hyperinsulinemic euglycemic conditions in rodents.  J Endocrinol. 2002;  175 R7-11
  CrossrefPubMedGoogle Scholar
• 34 Caixas A, Bashore C, Nash W, Pi-Sunyer F, Laferrere B. Insulin, unlike food intake, does not suppress ghrelin in human subjects.  J Clin Endocrinol Metab. 2002;  87 1902
  CrossrefPubMedGoogle Scholar
• 35 Degerblad M, Bengtsson B A, Bramnert M, Johnell O, Manhem P, Rosen T, Thoren M. Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy.  Eur J Endocrinol. 1995;  133 180-188
  PubMedGoogle Scholar

E. E. Müller

Department of Medical Pharmacology · University of Milan

via Vanvitelli 32 · 20129 Milan · Italy

Phone: +39(2)50317010-7012

Fax: +39(2)50317011

Email: eugenio.muller@unimi.it